Avid Bioservices Inc (CDMO)

[nuke661]

Carboat,

I pretty much agree with your statements and I find your posts pretty much a common sense approach to what's going on at this time.

However, with respect, there is one thing in your post I'm responding to that I do disagree with and I think it is the most important part of your post.

You stated:

If for any reason they can't get the data useable then I can't see a catalyst to avoid the delist/RS scenario.

First, I believe it will take at least six months to actually be de-listed if NASDAQ gives us what I have noticed in the past seems to be an automatic first extension. Second, there are going to be several POTENTIAL MAJOR catalysts coming our within this six month period and this is the part on which I most disagree with you. The catalysts are:
1)The POSSIBILITY of re-animating the 2nd line trial data (as a note Halloween is coming up so this would be the most appropriate time of year for that to happen. We need to get a doctor Frankenstein to help us with this)
2)Front line NSCLC results significantly better than control and SOC which it currently is trending towards. Considered by me to not be that high of risk at this current timeline because we haven't had an announcement yet of MOS and OS data. Our board team seems to have a pretty good handle on the timelines and how it correlates with the eventual release of the data. No need that I see to believe our prognosticators have suddenly lost their touch on this subject matter.
3)Pancreatic cancer for pretty much the same reasons as number 2) with the added and IMO very significant benefit, of proving yet again broad based use for Bavi's MOA and efficacy. I think this has the greater potential if Dr. Frankenstein can't come through for us with the 2nd line trial results.

I believe either one of these 3 events having a positive outcome would easily get us over 1 dollar and avoid the delisting and RS.

If we don't either 1 of those 3 events to have a positive outcome - and no other positive surprises from other events (e.g., Cotara partner or imaging deal) - then I believe we are done for and will be delisted and/or undergo a reverse split.